BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,219	3,935	4,732	5,160	6,590	5,430
Short-Term Investments	-	17.17	23.28	11.2	6.57	-
Trading Asset Securities	477.26	375.12	753.58	1,232	2,049	-
Cash & Short-Term Investments	3,696	4,327	5,509	6,403	8,646	5,430
Cash Growth	-21.57%	-21.46%	-13.96%	-25.94%	59.22%	345.99%
Accounts Receivable	2,025	1,679	1,464	2,223	1,244	1,576
Other Receivables	74.38	73.24	54.22	174.47	49.74	117.01
Receivables	2,099	1,752	1,518	2,397	1,294	1,693
Inventory	520.15	601.62	602.18	717.83	877.72	1,010
Other Current Assets	214.95	194.9	303.49	257.24	217.2	284.31
Total Current Assets	6,530	6,876	7,933	9,775	11,035	8,417
Property, Plant & Equipment	2,840	2,854	3,190	2,191	1,400	1,287
Long-Term Investments	580.14	1,306	1,252	1,328	898.21	449.29
Goodwill	36.47	36.47	47.11	47.11	47.11	47.11
Other Intangible Assets	355	359.6	418.82	410.89	245.46	146.76
Long-Term Deferred Tax Assets	276.73	230.47	241.58	236.29	200.29	162.06
Long-Term Deferred Charges	286.89	299.14	362.86	209.51	177.65	95.89
Other Long-Term Assets	1,396	580.15	167.17	187.25	250.86	589.6
Total Assets	12,301	12,542	13,613	14,385	14,254	11,195
Accounts Payable	867.95	1,137	864.6	1,025	805.32	873.23
Accrued Expenses	53.63	798.56	668.29	958.97	653.08	963.13
Short-Term Debt	10.01	24.91	-	-	5.01	563.3
Current Portion of Long-Term Debt	-	31.23	24.18	-	35.74	23.7
Current Portion of Leases	-	26.32	57.79	63.33	90.6	-
Current Income Taxes Payable	-	12.7	59.79	77.35	167.83	147.02
Current Unearned Revenue	545.45	637.83	699.71	929.35	1,410	840.88
Other Current Liabilities	850.69	173.59	922.68	901.93	216.41	390.86
Total Current Liabilities	2,328	2,842	3,297	3,956	3,384	3,802
Long-Term Debt	442.82	339.11	215.68	-	631.96	658
Long-Term Leases	78.11	49.7	67.75	136.68	84.44	73.89
Long-Term Unearned Revenue	67.52	15.11	15.39	19.68	36.07	49.1
Long-Term Deferred Tax Liabilities	11.98	24.89	13.13	51.56	5.19	1.48
Other Long-Term Liabilities	1.43	-	-	-	671.57	584.7
Total Liabilities	2,930	3,271	3,609	4,164	4,813	5,169
Common Stock	418.32	415.82	413.91	413.91	413.91	400.1
Additional Paid-In Capital	4,881	4,762	4,592	4,680	4,657	2,605
Retained Earnings	3,860	3,882	4,826	5,147	4,488	3,160
Treasury Stock	-57.61	-99.92	-115.32	-336.75	-87.95	-175.89
Comprehensive Income & Other	139.67	175.21	143.11	172	-152.57	-78.61
Total Common Equity	9,241	9,135	9,859	10,076	9,318	5,910
Minority Interest	130.38	136.75	144.78	145.09	122.87	115.64
Shareholders' Equity	9,372	9,272	10,004	10,221	9,441	6,026
Total Liabilities & Equity	12,301	12,542	13,613	14,385	14,254	11,195
Total Debt	530.93	471.27	365.4	200.01	847.75	1,319
Net Cash (Debt)	3,165	3,856	5,144	6,203	7,798	4,111
Net Cash Growth	-26.59%	-25.05%	-17.07%	-20.46%	89.68%	256.96%
Net Cash Per Share	7.62	9.35	12.47	15.12	18.94	10.30
Filing Date Shares Outstanding	416.87	412.38	379.44	409.91	409.91	396.09
Total Common Shares Outstanding	416.87	412.38	379.44	409.91	409.91	396.09
Working Capital	4,202	4,034	4,636	5,819	7,651	4,615
Book Value Per Share	22.17	22.15	25.98	24.58	22.73	14.92
Tangible Book Value	8,850	8,739	9,393	9,618	9,026	5,716
Tangible Book Value Per Share	21.23	21.19	24.76	23.46	22.02	14.43
Buildings	-	1,782	1,787	490.05	418.81	422.23
Machinery	-	2,362	2,195	1,841	1,612	1,635
Construction In Progress	-	205.67	418.08	752.33	38.5	53.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.